Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
13 employees
PolyVascular: Innovating non-surgical, medical-grade polymer valves for transcatheter pulmonary use.
HQ
Founded
2014
PolyVascular was founded with the core mission of revolutionizing pediatric cardiac care by developing non-surgical, medical-grade polymer valves for transcatheter pulmonary use. Their vision is to improve the quality of life for children born with congenital heart defects by reducing the need for frequent open-heart surgeries. PolyVascular offers a unique, minimally invasive pulmonary valve and delivery system specifically designed for children as young as two years old, addressing a critical gap in pediatric cardiac treatment.
Notable affiliated individuals include experts in pediatric cardiology and medical device innovation. PolyVascular has attracted significant interest from investors focused on healthcare advancements. Key achievements include the development and successful implementation of their polymer valve technology, which has shown promise in reducing surgical interventions and improving patient outcomes. The overall impact of PolyVascular's innovations lies in their potential to transform pediatric cardiac care, offering safer and more effective treatment options for young patients worldwide.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Medical Devices
Technology
Biotech
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was PolyVascular founded?
PolyVascular was founded in 2014.
Where is PolyVascular's headquarters located?
PolyVascular's headquarters is located in Houston, US.
When was PolyVascular's last funding round?
PolyVascular's most recent funding round was for $795k (USD) in July 2023.
How many employees does PolyVascular have?
PolyVascular has 13 employees as of Feb 5, 2024.
How much has PolyVascular raised to-date?
As of July 05, 2023, PolyVascular has raised a total of $825k (USD) since Jul 17, 2023.
Add Comparison
Total Raised to Date
$825k
USD
Last Update Jul 17, 2023
Last Deal Details
$795k
USD
Jul 17, 2023
Series Unknown
Current Employees
13
Last updated: Feb 5, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts